0001209191-15-071829.txt : 20150922 0001209191-15-071829.hdr.sgml : 20150922 20150922162146 ACCESSION NUMBER: 0001209191-15-071829 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150921 FILED AS OF DATE: 20150922 DATE AS OF CHANGE: 20150922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baird William D III CENTRAL INDEX KEY: 0001547658 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 151119572 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-21 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001547658 Baird William D III 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 0 1 0 0 Chief Financial Officer Common stock 2015-09-21 4 M 0 15236 16.7783 A 71811 D Common stock 2015-09-21 4 S 0 15236 16.7783 D 56575 D Stock Options (right to buy) 3.53 2015-09-21 4 M 0 5081 0.00 D 2017-01-01 2023-01-28 Common stock 5081 38259 D Stock Options (right to buy) 2.52 2015-09-21 4 M 0 2655 0.00 D 2017-06-01 2023-06-18 Common stock 2655 46224 D Stock Options (right to buy) 2.45 2015-09-21 4 M 0 7500 0.00 D 2018-01-01 2024-01-03 Common stock 7500 67500 D The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014. This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.72 to $17.72. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.72 to $17.72. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ William D. Baird, III 2015-09-22